HAE

Haemonetics

October 8, 2026 · pre-market

Rarity

4.60

Peak move

+22.80%

Float cap

$4.5B

Haemonetics is a medical technology company that sells blood and plasma collection systems, donor management software, and disposable kits to plasma centers and blood banks worldwide. Its hospital business supplies hemostasis testing analyzers, cell salvage devices, transfusion management software, and vascular closure products to clinicians and health systems. It also serves customers in over 90 countries from its Boston headquarters.

• reg_fd_disclosureOct 8

  CSL Plasma announced it expects to complete the rollout of Haemonetics' NexSys PCS devices with Persona PLUS technology and related disposables across all of its current U.S. plasma collection centers by the end of calendar 2027, expanding on the non-exclusive supply agreement signed Aug. 18, 2026, with Terumo BCT supporting the transition; Haemonetics is not updating its fiscal 2027 guidance.

  Websec.govWebtipranks.comWebpublicnow.comWebfinancialfilings.comWebwiseek.ai
• peer_disclosureOct 8

  Terumo Corporation said its Terumo BCT unit and CSL Plasma mutually agreed to terminate their source plasma collection device supply agreement after a transition period, and Terumo expects about US$610 million in losses, including roughly US$450 million of non-cash impairment, and cut its FY ending March 2027 profit guidance.

  Webfinancialfilings.com